The Respiratory Syncytial Virus Vaccines Market is witnessing steady growth as global awareness increases around the prevention of respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in infants, young children, and older adults. RSV vaccines are designed to reduce the severity and incidence of infection, particularly among high-risk populations, an... https://www.databridgemarketresearch.com/reports/global-respiratory-syncytial-virus-vaccines-market